Clinical News

FDA Alerts Pharmacists to Potential for Injury When Dispensing Similar-Sounding Drugs Durezol and Durasal

12/29/2011 0 Comments Contact Our News Editors

FDA is alerting pharmacists and other health care professionals of potential injury due to confusion between the FDA-approved eye medicine Durezol (difluprednate ophthalmic emulsion) 0.05% and the unapproved prescription topical wart remover Durasal (salicylic acid) 26%.

There has been one report of serious injury when a pharmacist mistakenly gave an eye surgery patient Durasal, the salicylic acid–containing wart remover, instead of the prescribed Durezol eye drops. Durezol is approved for treatment of inflammation and pain association with ocular surgery.

News Source:

U.S. Food and Drug Administration

Click here to read entire article...